|
|
Current Status of Useful Written Prescription
Drug Information for Patients
Public Workshop
DoubleTree Hotel, Rockville, MD
February 29 - March 1, 2000
AGENDA
| Day 1 |
| 1:00 - 1:30 |
Moderator |
Nancy M. Ostrove, Ph.D.
FDA, CDER, Branch Chief Division of Drug Marketing, Advertising, and Communications |
|
Welcome |
Nancy Smith, Ph.D.
FDA, CDER, Director
Office of Training and
Communication |
|
Why are we here? |
Thomas J. McGinnis, R.Ph.
FDA, Office of Policy
Director of Pharmacy Affairs |
| 1:30 - 1:45 |
History of Recent Private-Sector Information Provision
Efforts |
Judith O'Brien
The Keystone Center |
| 1:45 - 2:00 |
Background on the Patient Information Project |
Karen Oster
National Association of Boards of Pharmacy |
| 2:00 - 3:00 |
1999 Patient Information Assessment |
Bonnie Svarstad, Ph.D.
Professor of Pharmacy
University of Wisconsin |
| 3:00 -3:15 |
Break |
|
| 3:15 - 5:00 |
Assessment, cont. |
Dr. Svarstad |
| 5:00 - 5:30 |
Questions from the audience |
Nancy M. Ostrove |
| |
|
|
| Day 2 |
| 8:30 - 9:00 |
Continental Breakfast |
|
| 9:00 - 9:30 |
Welcome |
Nancy M. Ostrove |
|
Opening Remarks |
Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research |
|
Small Group Assignments |
Nancy M. Ostrove |
| 9:30 - 9:45 |
Move to break out rooms |
|
| 9:45 - 12:00 |
Break out sessions |
|
| 12:00 - 1:15 |
Lunch |
|
| 1:15 - 2:45 |
Welcome Back
Results from small group breakout sessions |
|
| 2:45 - 3:00 |
Closing Remarks |
|
 Back to Rx 2000 Home
FDA/Center for Drug Evaluation and Research
Last Updated: March 08, 2001
Originator: OTCOM/DML
HTML by PKS;CSA |
